A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here
Friday, 4 March 2011
This three-page article, which you can access here, summarises the focal points of the four England and Wales SPC cases which have been referred for preliminary rulings by the Court of Justice of the European Union, emphasises their importance in defining the balance between the two sides of the pharma industry and doubts that the outstanding questions will be resolved in the course of this calendar year.